Context Therapeutics Inc. CNTX
0.18 USD 0.00 (-0.39%)
As ofNov 16, 2026, 9:30 AM EST
0.18 Day range 0.1839
0.18 52-week range 3.62
- YTD
- -87.75%
- 1 year
- -84.34%
News
benzinga.com Context Therapeutics Q3 EPS $(0.08) Beats $(0.11) Estimate Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.11) by 27.27 percent. This is a 20 percent increase over losses of…
globenewswire.com Context Therapeutics Reports Third Quarter 2026 Financial Results and Pipeline Progress CTIM-76 weekly dosing at 140–280 µg in heavily pretreated PROC: 22% confirmed ORR, 56% confirmed DCR, and median PFS of 5.6 months
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 29.7% to $0.42 during Friday's pre-market session. The company's market cap stands at $63.6 million. Electra Therapeutics (NASDAQ:ETRA)…
